Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
Hua Medicine Announces First-Ever Successful Phase II Monotherapy... 10/17/2016
BeiGene Granted CFDA Approval for Clinical Trial of Anticancer mA... 9/12/2016
Nobel Laureate Tu Youyou's Team Reports New Progress on Artemisin... (free) 9/6/2016
BeiGene Approved for Clinical Trials in China with PARP Inhibitor... (free) 8/18/2016
CFDA Accepts Eisai's NDA for Anticancer Halaven 8/9/2016
Immunicum to be Granted Chinese Patent for Anticancer CD70 Techno... 7/26/2016
Chinese Scientists to Embark on First Human Trial with CRISPR Gen... 7/25/2016
Domestic HPV Vaccine in Final Stage of Clinical Trial 7/22/2016
Yisheng Biopharma and USAMRIID Announce Positive Animal Results o... (free) 7/15/2016
BeiGene Announces First Patient Dosing in China for BTK Inhibitor... 7/6/2016
Health Care: China's Innovation Hotbed 6/27/2016
Page:3/3    Total number of articles:71  :[1][2][3]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links